APOLLO THERAPEUTICS
LIVE

Serial Number

90798637

Owner

Apollo Therapeutics LLP

Attorney

Benjamin Charkow

Filing Date

Jun 28, 2021

Add to watchlist:

No watchlists yet
View on USPTO

APOLLO THERAPEUTICS Trademark

Serial Number: 90798637 • Registration: 7172183

APOLLO THERAPEUTICS is a trademark filed by Apollo Therapeutics LLP on June 28, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Apollo Therapeutics LLP

52 Princes Gate, Exhibition Road
London SW72PG , GB

Entity Type: 99

APOLLO THERAPEUTICS NO.2 LLP

52 PRINCES GATE EXHIBITION ROAD
LONDON SW7 2PG , GB

Entity Type: 21

APOLLO THERAPEUTICS LIMITED

3RD FLOOR, 22 STATION ROAD
CAMBRIDGE CB1 2JD , GB

Entity Type: 24

Trademark Details

Filing Date

June 28, 2021

Registration Date

September 26, 2023

Published for Opposition

April 11, 2023

Goods & Services

Scientific, medical and pharmaceutical research and development services; clinical research in the field of the use of biologics, biosimilars, small molecules, gene-engineered cell therapy and vaccines for the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases; pharmaceutical drug development services; scientific investigations for medical purposes; medical laboratory services; laboratory research services related to pharmaceuticals; advisory services relating to medical and pharmaceutical science research in the field of the use of biologics, biosimilars, small molecules, gene-engineered cell therapy and vaccines for the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases; research and development of pharmaceutical preparations

Therapeutic pharmaceuticals for the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases; pharmaceutical preparations, namely biologics, biosimilars, small molecules, gene-engineered cell therapy in the nature of cells for medical use, namely autologous gene-engineered cells; medical preparations for the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases

Education services, namely, providing instruction in the field of pharmaceutical and therapeutic medical education; arranging and conducting of conferences, congresses, courses, in particular in the fields of medicine and pharmaceuticals; publishing services, namely, the publication of periodicals, books, magazines, and articles in the field of medicine, pharmaceuticals, and therapeutics; publication of periodicals, books, magazines, articles, in particular in the fields of medicine, pharmaceuticals and therapeutics

Collection of data and management of data for business purposes in connection with clinical research, testing, trial and development of pharmaceuticals, therapeutics and medical devices; computerized database management and data processing services in the field of medical, pharmaceutical and therapeutic treatment

Financial sponsorship in the form of providing financial resources to non-hospital partnerships, associations and companies, to aid in the research, development, production, import, export, retail, wholesale, promotion, commercial distribution and commercialisation of pharmaceutical, therapeutic and medicinal products and preparations

Non-emergency and non-clinical medical and pharmaceutical consulting services related to the use of pharmaceutical preparations, namely biologics, biosimilars, small molecules, gene-engineered cell therapy and vaccines; non-emergency medical analysis services for diagnostic and treatment purposes related to the use of pharmaceutical preparations, namely biologics, biosimilars, small molecules, gene-engineered cell therapy and vaccines, provided by medical laboratories; medical analysis and examination services related to the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases, provided by medical laboratories; medical treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases; advisory services relating to medical and pharmaceutical science, namely, medical advisory services and pharmaceutical advisory services in the field of the use of biologics, biosimilars, small molecules, gene-engineered cell therapy and vaccines for the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 4, 2026 ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 26, 2025 ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 5, 2025 ASGN
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 26, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 26, 2023 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Aug 21, 2023 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 21, 2023 AITU
NOTICE OF ALLOWANCE CANCELLED
Jul 10, 2023 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Jul 10, 2023 D1BR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 6, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 11, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 11, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 22, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 3, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 1, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 1, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 1, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 1, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 21, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 21, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 21, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 6, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jan 6, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jan 6, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 10, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 9, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 9, 2022 TROA
ASSIGNED TO EXAMINER
Aug 30, 2022 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 7, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jun 7, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 7, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 7, 2022 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 2, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jun 2, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jun 2, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 18, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 10, 2021 NWOS
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 6, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 6, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 6, 2021 REAP
NEW APPLICATION ENTERED
Jul 1, 2021 NWAP